Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964413
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2023-06-29
Brief Title:
Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
Sponsor:
InflaRx GmbH
Organization:
InflaRx GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-29
First Submit QC Date:
July 24 2023
Study First Post Date:
2023-07-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-31
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL